Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The BD™ HLA-B27 system is a qualitative two-color direct immunofluorescence method for the rapid detection of HLA-B27 antigen expression in erythrocyte-lysed whole blood (LWB) using the BD FACSCanto™ family of flow cytometers, or the BD FACSCalibur™, BD FACSort™, or BD FACScan™ flow cytometer. Contents: Anti-HLA-B27 FITC / CD3 PE, HLA-B27 calibration beads, and BD FACS™ Lysing Solution.
• Store Reagent A and Reagent C upright at 2° to 8°C. Do not use after the expiration date shown on the label.
• Store Reagent B, undiluted, at 2° to 25°C. When diluted, store at room temperature (20° to 25°C) for up to one month.
• Do not freeze the reagents or expose them to direct light during storage or incubation with cells. Keep reagent vials dry.
| Description | Quantity/Size | Part Number |
|---|---|---|
| BD FACS™ Lysing Solution | N/A | 91-0177 |
| N/A | N/A | 91-0176 |
| N/A | N/A | 91-0175 |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For In Vitro Diagnostics Use.
Documents are subject to revision without notice. Please verify you have the correct revision of the document, and always refer back to BD's eIFU website for the latest and most up to date information.